Gyre Therapeutics, Inc. · NASDAQ:GYRE
Ye Weiguo sold 11,000 Gyre Therapeutics, Inc. shares (Form 4)
Traded Jun 9 to Jun 18, 2026 · Filed Jun 22, 2026
From Jun 9 to Jun 18, 2026, Ye Weiguo (Chief Operating Officer) sold 11,000 Gyre Therapeutics, Inc. shares at an average US$6.25 for US$68,700, leaving 700,000 shares. Filed Jun 22, 2026 (Form 4).
- Sold
- 11,000 shares
- Price
- US$6.25 average (US$6.15 to US$6.35)
- Value
- US$68,700
- Holding after
- 700,000 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Common Stock | Option exercise | 3,000 | US$0.75 | 703,000 | Direct |
| Jun 9, 2026 | Common Stock | Sale | 3,000 | US$6.15 | 700,000 | Direct |
| Jun 10, 2026 | Common Stock | Option exercise | 5,000 | US$0.75 | 705,000 | Direct |
| Jun 10, 2026 | Common Stock | Sale | 5,000 | US$6.24 | 700,000 | Direct |
| Jun 18, 2026 | Common Stock | Option exercise | 3,000 | US$0.75 | 703,000 | Direct |
| Jun 18, 2026 | Common Stock | Sale | 3,000 | US$6.35 | 700,000 | Direct |
Source
Related
- Gyre Therapeutics, Inc.
- Ye Weiguo
- Gyre Therapeutics, Inc. shareholders
- Form 4 · Ye Weiguo · Jun 15, 2026
- Form 4 · Ye Weiguo · Jun 11, 2026
- Form 4 · Ye Weiguo · Jun 8, 2026
- Form 4 · Ye Weiguo · May 27, 2026
- Form 4 · Ye Weiguo · May 22, 2026
- Form 4 · Ye Weiguo · May 20, 2026
- Form 4 · Ye Weiguo · May 18, 2026
- Form 4 · Luo Ying · May 7, 2026
- Schedule 13D/A · Songjiang Ma · May 7, 2026
- Schedule 13D/A · GNI Group Ltd. · May 6, 2026